- Home
- RLYB vs BNGO Comparison
RLYB vs BNGO Comparison
Compare RLYB & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- BNGO
- Stock Information
- Founded
- RLYB 2018
- BNGO 2003
- Country
- RLYB United States
- BNGO United States
- Employees
- RLYB N/A
- BNGO N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- RLYB Health Care
- BNGO Industrials
- Exchange
- RLYB Nasdaq
- BNGO Nasdaq
- Market Cap
- RLYB 24.1M
- BNGO 24.3M
- IPO Year
- RLYB 2021
- BNGO 2018
- Fundamental
- Price
- RLYB $0.64
- BNGO $1.52
- Analyst Decision
- RLYB Hold
- BNGO Buy
- Analyst Count
- RLYB 2
- BNGO 4
- Target Price
- RLYB N/A
- BNGO $7.67
- AVG Volume (30 Days)
- RLYB 263.4K
- BNGO 327.9K
- Earning Date
- RLYB 11-06-2025
- BNGO 11-13-2025
- Dividend Yield
- RLYB N/A
- BNGO N/A
- EPS Growth
- RLYB N/A
- BNGO N/A
- EPS
- RLYB N/A
- BNGO N/A
- Revenue
- RLYB $674,000.00
- BNGO $27,426,000.00
- Revenue This Year
- RLYB N/A
- BNGO N/A
- Revenue Next Year
- RLYB N/A
- BNGO $24.54
- P/E Ratio
- RLYB N/A
- BNGO N/A
- Revenue Growth
- RLYB 12.71
- BNGO N/A
- 52 Week Low
- RLYB $0.22
- BNGO $1.47
- 52 Week High
- RLYB $1.24
- BNGO $22.80
- Technical
- Relative Strength Index (RSI)
- RLYB 53.76
- BNGO 30.92
- Support Level
- RLYB $0.62
- BNGO $1.47
- Resistance Level
- RLYB $0.72
- BNGO $1.70
- Average True Range (ATR)
- RLYB 0.05
- BNGO 0.10
- MACD
- RLYB 0.00
- BNGO -0.00
- Stochastic Oscillator
- RLYB 37.50
- BNGO 10.31
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.